Explore All 3109 Add-on Acquisition Life Science Deals - Search the Database Free
M&A Deal Summary |
|
|---|---|
| Date | September 27, 2019 |
| Target | Nalpropion Pharmaceuticals |
| Sector | Life Science |
| Buyer(s) | Currax Pharmaceuticals |
| Deal Type | Add-on Acquisition |
FILTER BY
Currax Pharmaceuticals LLC is a specialty pharmaceutical business focused on acquiring and commercializing prescription drugs within the U.S. market. Currax distributes a range of both Branded and generic pharmaceutical products, including Silenor®, Treximet®, Zohydro® ER with BeadTek® and the authorized generic of Treximet®.
| Deal Context for Buyer | # |
|---|---|
| Overall | 2 of 2 |
| Sector: Life Science | 2 of 2 |
| Type: Add-on Acquisition | 2 of 2 |
| State: California | 1 of 1 |
| Country: United States | 2 of 2 |
| Year: 2019 | 2 of 2 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2019-05-01 |
Pernix Therapeutics Holdings
Morristown, New Jersey, United States Pernix Therapeutics Holdings, Inc. is a pharmaceutical company developing branded and generic pediatric products. Pernix Therapeutics was founded in 1996 and is based in Morristown, New Jersey. |
Buy | $76M |
